Publication Date:
2022
abstract:
"The increasing occurrence of infectious complications during ICIs that may limit their potential therapeutic effects needs to be managed by a multidisciplinary team, including oncologists, microbiologists/virologists and infectious disease specialists."
Iris type:
1.1 Articolo in rivista
Keywords:
IRIS; immune checkpoint inhibitors; immune exhaustion; immune reconstitution inflammatory syndrome; immune-related adverse effects; infectious complications; virome
List of contributors:
Lasagna, Angioletta; Cassaniti, Irene; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo
Published in: